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Post Lactation Giant Breast Hamartoma: Challenges 
of Diagnosis and Surgical Management 
-Breast hamartomas are rare, benign breast tumors composed of varying amounts of fibrotic, 
fatty, and glandular elements.
-They are also named fibroadenolipoma, adenolipoma, and lipofibroadenoma depending on 
the predominant tissue composition. 
-Rare subtypes include myoid, chondroid and pseduoangiomatous stroma.
-The incidence is 0.1 - 0.7%, but thought to be higher as 75% of breast hamartomas are 
asymptomatic and 66% are not palpable.
-Incidence is also likely higher because their histological composition, clinical presentation, and 
appearance on imaging are often similar to a fibroadenoma. 
-Comprise 4.8% of all benign breast lesions and can present in women from 24 to 76 years old, 
but usually in women over 35
-It is important to accurately diagnose breast hamartomas because of it’s malignant potential. 
-Most common symptoms include a painless, palpable, mobile mass that is circumscribed and 
often round to oval shaped grossly and on imaging.
-Usually slow growing, but can lead to significant breast asymmetry as in our patient.
-Exact cause is unknown, but it is thought to arise from dysgenesis and is not a true tumor.
-Can occur as a single tumor or in association with Cowden or Bannayan-Riley-Ruvalcaba
syndrome, which can lead to the development of multiple hamartomas in various organ 
systems. 
-Usually found incidentally on screening mammography, but often require tissue biopsy for 
confirmation. 
-Liposarcomas should be considered on the imaging differential because they are malignant 
and have metastatic potential 
Our patient is a 38 year old, premenopausal African American woman with a past medical 
history of bilateral fibroadenomas with subsequent surgical excisions. She delivered her first 
child and breastfed at the age of 35. Shortly after giving birth, the patient noticed an enlarging 
right breast lesion, prompting mammogram and US evaluation. Imaging studies at this time did 
not visualize an abnormality, but noted increased breast density consistent with breastfeeding. 
The patient was recommended additional imaging with contrast enhanced spectral 
mammography (CESM), but initially declined. Eight months later, the patient elected to 
proceed with CESM and was not breastfeeding at this time. The CESM findings demonstrated a 
large circumscribed fat density mass in the right lower outer breast measuring approximately 
13.1 cm and consistent with a benign breast lipoma. The patient underwent a second bilateral 
breast ultrasound revealing a circumscribed oval isoechoic mass in the right lower outer 
quadrant measuring 3.9 x 10.1 cm, consistent with the sonographic appearance of a lipoma. 
Annual mammography was recommended.
Imaging: Follow- up mammographic imaging was now significant for a large encapsulated 
lucent mass encompassing the entire outer central right breast and consistent once again with 
a breast lipoma. The patient had no further workup at this time. She presented to the breast 
surgical oncology department nine months later after noting a rapidly enlarging mass in her 
right breast.  She complained of right breast tenderness, denied erythema, thinning of skin, 
spontaneous nipple discharge, or nipple inversion. She also denied a history of high risk breast 
lesions. Age at first parity was 35, she breastfed for 12 months, and was taking oral 
progesterone for contraceptives. She denied a history of fertility treatments or hormone 
replacement therapy.
Physical exam: Her breasts were notably asymmetric. The right breast measured a 38DD 
and the left was a 34B with no evidence of skin retraction, erythema, scaling, or nipple 
inversion. Milky discharge was expressed from the right breast and a mass spanning the 6:00 to 
10:00 position was palpated as approximately 12 x 12 cm. At the 6:00 and 8:00 position, the 
edges were notable for small nodules. The mass was firm, mobile, and not fixed to the 
underlying chest wall or tethered. There was no cervical, supraclavicular, infraclavicular, or 
axillary lymphadenopathy bilaterally. 
Imaging
-Our patient’s breast hamartoma was not detected with traditional imaging while lactating, making 
a somewhat difficult diagnosis more challenging. This led to the use of uncommon imaging 
modalities to detect the breast hamartoma when she presented after lactation cessation (CESM 
and MRI with and without contrast).
-The increased lobules and ducts during lactation increase breast density and can obscure masses. 
Ultrasound and mammography did not initially detect our patient’s mass.
-CESM was the first imaging study to detect a mass in our patient and accurately identified the 
predominantly fatty tissue composition of the mass. CESM uses Full Field Digital Mammography 
with IV  contrast, which is specifically useful in the diagnosis of this patient because it enhances the 
sensitivity for detecting breast cancer and suspicious masses, especially in patients with 
heterogeneously and extremely dense breasts. CESM may be considered in the diagnostic workup 
of patients who are lactating or have dense breasts, especially in women with inconclusive 
screening on mammogram and ultrasound, such as our patient.
-MRI with and without contrast was also helpful in leading to a non-invasive and accurate diagnosis 
of a breast hamartoma. MRI with and without contrast may also be considered in the evaluation of 
post- partum breast masses, especially if previous imaging is indeterminate.
Surgical Challenges
-Our patient developed rapid growth of her right breast after cessation of lactation. Rapid and 
disfiguring growth is concerning for a malignant mass with possible metastatic potential and the 
mass created discomfort and visible asymmetry. Excisional biopsy is diagnostic and therapeutic, but
was complicated by the need for plastics reconstruction because of the surgical challenges created 
by the asymmetry.
-Oncoplastic breast surgery was required to ensure adequate symmetry and margins. Multiple 
techniques can be used. Local tissue rearrangement has taken favor as it involves moving 
subcutaneous and glandular breast tissue to fill in the defect created by tumor excision.
Hormonal Influences
-Lactation cessation may be implicated in the rapid growth of our patient’s hamartoma because 
the majority of breast hamartomas are composed of epithelial and stromal cells, which have been 
shown to contain estrogen and progesterone receptors. It is known that breast hamartoma cells 
are influenced by estrogen and progesterone just as the epithelial cells comprising normal breast 
tissue. Cowden syndrome results from a PTEN mutation and a similar pathophysiological 
mechanism may be involved in the development of breast hamartomas as well. PTEN is a tumor 
suppressor gene that inhibits PI3K/AKT signaling, preventing estrogen dependent gene expression.
Without PTEN suppression of PI3K/AKT, epithelial and endometrial cells reliant on estrogen 
receptor trophic signal can grow uncontrollably. This theory may also lead to consideration of 
alternative treatments to shrink or delay growth of rapidly enlarging breast hamartomas with 
medications such as oral contraceptives. 
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Follow up imaging: A bilateral MRI of the breast with and without contrast confirmed presence of 
a circumscribed enhancing 12.3 x 6.9 x 8.7 cm mass in the upper outer and lower outer quadrant of 
the right breast, anterior, middle, and posterior thirds. This mass was thought to be most 
consistent with a hamartoma. There was also a 6mm enhancing mass in the right breast at the 3:00 
position, 7 cm from the nipple that was recommended targeted US evaluation and biopsy.  The left 
breast was unremarkable and there was no axillary or internal mammary lymphadenopathy. 
A targeted breast ultrasound was performed of the right subareolar breast at the 3:00 position. 
The biopsy showed cores of benign adipose tissue and breast tissue, no malignancy or atypia was 
noted. The pathologist’s histologic differential diagnosis included a hamartoma, lipoma, and non-
lesional breast tissue.
Histopathology: Given the patient’s asymmetry, pain and rapidly growing mass, she was 
recommended right breast surgical excision with immediate reconstruction with breast and plastic 
surgery. On final pathology, the specimen measured 15x13x4 cm, which contained benign, 
circumscribed, encapsulated, lobulated yellow adipose tissue throughout, no breast tissue or 
densities identified grossly. The final diagnosis was a “hamartoma-primarily composed of adipose 
tissue with scattered foci of benign breast tissue.”
Our goal is to inform clinicians about the challenges of diagnosing breast hamartomas in 
pregnant and lactating women, as well as women with dense breasts. It is appropriate to 
follow one’s clinical suspicion with imaging and to consider CESM and MRI with and without 
contrast in lactating women and women with dense breasts as these imaging modalities 
allowed us to come to a more accurate diagnosis in this case. Although our patient did not get 
the recommended CESM until after she stopped breastfeeding, the literature on CESM suggest 
that it’s sensitivity for detecting masses in heterogeneously and extremely dense breasts may 
have been able to detect this mass earlier, preventing rapid enlargement and the need for 
plastics reconstruction. Breast hamartomas should be on the differential for post- partum 
breast masses as pregnancy and lactation may affect the growth of hamartoma cells, which is 
the similar to normal breast tissue. It is known that the majority of breast hamartomas are 
benign, but obtaining a diagnosis with advanced imaging and histopathology in a timely 
manner is paramount. Consequences of delayed diagnosis include potential for malignant 
transformation, metastatic disease, and rapid growth involving significant breast asymmetry 
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(FIGURE 1)
Breast hamartoma before complete excision.
(FIGURE 3) 
Gross specimen of breast hamartoma, 
primarily composed of adipose tissue 




Breast hamartoma removed from the right 
upper and lower quadrant of the breast.
.
